The NIH Clinical Center is a hospital solely dedicated to clinical research at the National Institutes of Health campus in Bethesda, Maryland.

During the past decade, National Institutes of Health Clinical Center, 9000 Rockville Pike conducted 161 clinical trials. In the 10-year time frame, 161 clinical trials started and 371 clinical trials were completed, i.e. on average, 230.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 163 clinical trials were completed. i.e. 8150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Institutes of Health Clinical Center, 9000 Rockville Pike" #1 sponsor was "National Cancer Institute (NCI)" with 437 trials, followed by "National Institute of Neurological Disorders and Stroke (NINDS)" with 251 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 193 trials sponsored, "National Heart, Lung, and Blood Institute (NHLBI)" with 180 trials sponsored and "National Institute of Mental Health (NIMH)" with 180 trials sponsored. Other sponsors include 588 different institutions and companies that sponsored additional 60 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Institutes of Health Clinical Center, 9000 Rockville Pike" #1 collaborator was "National Institutes of Health Clinical Center (CC)" with 17 trials as a collaborator, "National Cancer Institute (NCI)" with 14 trials as a collaborator, "The Emmes Company, LLC" with 10 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 9 trials as a collaborator and "Center for Neuroscience and Regenerative Medicine (CNRM)" with 8 trials as a collaborator. Other collaborators include 160 different institutions and companies that were collaborators in the rest 111 trials.

According to Clinical.Site data, the most researched conditions in "National Institutes of Health Clinical Center, 9000 Rockville Pike" are "Healthy" (138 trials), "Healthy Volunteers" (36 trials), "Prostate Cancer" (34 trials), "Breast Cancer" (32 trials) and "HIV Infections" (32 trials). Many other conditions were trialed in "National Institutes of Health Clinical Center, 9000 Rockville Pike" in a lesser frequency.

Most popular intervention types in "National Institutes of Health Clinical Center, 9000 Rockville Pike" are "Drug" (770 trials), "Biological" (149 trials), "Procedure" (107 trials), "Other" (64 trials) and "Device" (43 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (77 trials), "Cyclophosphamide" (52 trials), "Fludarabine" (35 trials), "Aldesleukin" (28 trials) and "Bevacizumab" (16 trials). Other intervention names were less common.

The vast majority of trials in "National Institutes of Health Clinical Center, 9000 Rockville Pike" are 1653 trials for "All" genders, 92 trials for "Female" genders and 64 trials for "Male" genders.

Currently, there are NaN active trials in "National Institutes of Health Clinical Center, 9000 Rockville Pike". undefined are not yet recruiting, 7 are recruiting, 22 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1441 completed trials in National Institutes of Health Clinical Center, 9000 Rockville Pike, undefined suspended trials, and 314 terminated clinical trials to date.

Out of the total trials that were conducted in National Institutes of Health Clinical Center, 9000 Rockville Pike, 467 "Phase 1" clinical trials were conducted, 561 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 24 trials, and there were also 28 trials that are defined as “Not Applicable".